Watson Expands Generics Biz With $562M Specifar Buy
Watson Pharmaceuticals Inc. said Wednesday that it had paid $562 million in cash for Specifar Pharmaceuticals SA, a privately held Greek generics business, marking the latest deal in a wave of...To view the full article, register now.
Already a subscriber? Click here to view full article